Anika Therapeutics (ANIK) Net Cash Flow (QoQ) (2010 - 2026)
Anika Therapeutics (ANIK) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,600.90% |
| Dec 31, 2025 | -108.66% |
| Sep 30, 2025 | 1,033.52% |
| Jun 30, 2025 | 85.91% |
| Mar 31, 2025 | 23.29% |
| Dec 31, 2024 | -542.10% |
| Sep 30, 2024 | 85.83% |
| Jun 30, 2024 | -32.71% |
| Mar 31, 2024 | -296.59% |
| Dec 31, 2023 | -62.02% |
| Sep 30, 2023 | 138.34% |
| Jun 30, 2023 | -121.95% |
| Mar 31, 2023 | -379.36% |
| Dec 31, 2022 | 61.56% |
| Sep 30, 2022 | -426.04% |
| Jun 30, 2022 | 127.16% |
| Mar 31, 2022 | -223.24% |
| Dec 31, 2021 | 152.97% |
| Sep 30, 2021 | -341.73% |
| Jun 30, 2021 | 323.95% |